ArticleCancers2022

Comparison of Proclarix, PSA Density and MRI-ERSPC Risk Calculator to Select Patients for Prostate Biopsy after mpMRI.

Miriam Campistol et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.